Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone

Ann Clin Biochem. 2012 Mar;49(Pt 2):204; author reply 204-5. doi: 10.1258/acb.2011.011207. Epub 2012 Feb 15.

Authors

David John Halsall, Mark Gurnell

PMID: 22337707
DOI: 10.1258/acb.2011.011207

No abstract available

Publication types

Letter
Comment

MeSH terms

Cushing Syndrome / blood*
Drug Monitoring / methods*
Humans
Hydrocortisone / blood*
Metyrapone / therapeutic use*
Steroid 11-beta-Hydroxylase / antagonists & inhibitors*

Substances

Steroid 11-beta-Hydroxylase
Hydrocortisone
Metyrapone